Literature DB >> 19328392

Sunitinib-induced myxedema coma.

Shey-Ying Chen1, Pei-Chieh Kao, Zhong-Zhe Lin, Wen-Chu Chiang, Cheng-Chung Fang.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19328392     DOI： 10.1016/j.ajem.2008.07.012

Source DB:  PubMed          Journal:  Am J Emerg Med        ISSN： 0735-6757            Impact factor:   2.469


× No keyword cloud information.
  4 in total

Review 1.  Thyroid dysfunction from antineoplastic agents.

Authors:  Ole-Petter Riksfjord Hamnvik; P Reed Larsen; Ellen Marqusee
Journal:  J Natl Cancer Inst       Date:  2011-10-18       Impact factor: 13.506

2.  Acute renal failure: a rare side effect of sunitinib therapy.

Authors:  Hameem I Kawsar; Saurabh Bansal; Jonathan L Myles
Journal:  Med Oncol       Date:  2012-06-09       Impact factor: 3.064

3.  Thyroid hormone autoantibodies: are they a better marker to detect early thyroid damage in patients with hematologic cancers receiving tyrosine kinase inhibitor or immunoregulatory drug treatments?

Authors:  P Mondello; M Mian; V Pitini; S Cuzzocrea; A Sindoni; M Galletti; M Mandolfino; D Santoro; S Mondello; C Aloisi; G Altavilla; S Benvenga
Journal:  Curr Oncol       Date:  2016-06-09       Impact factor: 3.677

Review 4.  Hypothyroidism after a cancer diagnosis: etiology, diagnosis, complications, and management.

Authors:  Yvette Carter; Rebecca S Sippel; Herbert Chen
Journal:  Oncologist       Date:  2013-12-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.